|
$452,335
|
To examine trends in prescription drug prices and Medicare Part D formulary coverage and broadly disseminate the findings policy briefs, papers, and convenings.
|
2018 - 2020
|
LJAF
|
|
$950,796
|
To raise awareness and provide evidence-based policy solutions to improve Medicare's fiscal sustainability.
|
2021 - 2023
|
LJAF
|
|
$684,107
|
To support a survey and analysis on contraceptive coverage and access.
|
2021 - 2023
|
LJAF
|
|
$370,000
|
To provide researchers, policymakers, and the public with accessible, unbiased information about the Medicaid pharmacy benefit and policy options to lower Medicaid drug spending.
|
2019 - 2021
|
LJAF
|
|
$200,000
|
To support Kaiser Health News in providing independent reporting on pharmaceutical drug development and pricing.
|
2017 - 2018
|
LJAF
|
|
$1,060,500
|
To support Kaiser Health News in providing independent reporting on pharmaceutical drug development and pricing.
|
2016 - 2018
|
LJAF
|
|
$1,268,148
|
To support work in bringing greater visibility to the business practices, financial incentives, and other market forces that drive up health care prices.
|
2022 - 2024
|
LJAF
|
|
$942,601
|
To produce nonpartisan, educational analyses, policy briefs, and explainers examining the effect of proposed health policy changes on prices, costs and affordability.
|
2019 - 2022
|
LJAF
|
|
$2,000,000
|
To support Kaiser Health News.
|
2021 - 2023
|
LJAF
|
|
$1,000,000
|
To provide general operating support for Kaiser Health News
|
2020 - 2021
|
LJAF
|
|
$600,000
|
To support reporting focused on reproductive health.
|
2021 - 2023
|
LJAF
|
